AWARDPURCHASE ORDERSmall business
Purchase order W81K0022P0048WELLS PHARMA OF HOUSTON LLC
Overview
Award facts
- Net obligations
- $408.9K
- $408,899of $639.6K potential value
- Period of performance
- Jan 21, 2022 to Sep 30, 2025
- Ended
- Modifications
- 12
- Latest action Mar 27, 2025
- Contract type
- Purchase order
- PIID W81K0022P0048
Description of requirement
NOREPINEPHRINE
Dates and value
- Award date
- Signed on Jan 21, 2022
- Potential end of performance
- Sep 29, 2025
- Current value
- $639,603Base and exercised options
- Potential value (if all options are exercised)
- $639,603
Obligations by fiscal year of action
- FY2025: $15,382
- FY2024: $151,278
- FY2023: $242,239
Total across 3 fiscal years: $408,899
The Department of Defense funded and awarded this contract. DoD contract actions are withheld at the source for about 90 days after signature, so actions signed after Aug 18, 2026 are not yet public.
Source: Federal Procurement Data System contract actions as published by SAM.gov and USAspending.gov; latest action recorded Mar 27, 2025. View on USAspending · Recipient on SAM.gov
Recipient
LocationHOUSTON, TX
UEIKZYSEB9YNPR4
CAGE code8NE12
Business sizeSmall businessSize at award, per the contracting officer
Organization typeCorporate not tax exempt
Parent companyWELLS PHARMA OF HOUSTON LLC
Business types and certifications
For-profit organizationLimited liability companyCorporation (not tax-exempt)
As represented in SAM.gov at the time of the action.
Subcontracting network
The prime, the subcontractors on this award, and their own subcontractors.
Agency and place
Awarding and funding
- Awarded by
- Department of Defense
- Department Of The Army
- W40M MRC0 WEST
- Funded by
- Department of Defense
- Defense Health Agency
- AMC BAMC FSH - MM
- Funded from
- Operation and maintenance; UndistributedProgram activities097-0130Federal accounts (agency financial reports)
Place of performance
- Place of performance
- Jbsa Ft Sam Houston, Bexar County, Texas 78234-4400
- Congressional district (place of performance)
- TX-21As reported at the time of the action
Classification and competition
Classification
- Product or service (PSC)
- 6505DRUGS AND BIOLOGICALS (product)
Competition
- Extent competed
- Not competed under SAPG
- Reason not competed
- SAP non-competition (FAR 13)SP2
- Solicitation procedures
- Simplified acquisitionSP1
- Set-aside
- No set-aside used
- Contract pricing
- Firm fixed priceJ
- Offers received
- 1
Solicitation and notices
- Solicitation ID
- W81K0022Q0012
- Solicitation date
- Jan 11, 2022
- Notices
- Special Notice posted Dec 15, 2021
- Sources Sought posted Dec 6, 2021
Contract details
- Subcontracting plan
- Plan not requiredB
- Service Contract Act labor standards
- No
- Commercial procedures
- Commercial products/servicesA
- Government-furnished property
- Transaction does not use GFE/GFPN
- Bundled requirement
- Not bundledH
- Consolidated requirement
- Not consolidatedD
- Undefinitized action (terms not final)
- No
Linked notices
Notice | Notice ID | Type | Link | Posted |
|---|---|---|---|---|
Transaction history
Modification history
- Base award
- Jan 21, 2022
- Latest action
- Mar 27, 2025 — Terminated for convenienceModification P00012; obligation change -$268,010
- Latest substantive action
- Mar 27, 2025 — Terminated for convenienceModification P00012; obligation change -$268,010
- Latest funding action
- Nov 18, 2024 — Funding onlyModification P00011; obligation change +$283,392; funding only: changes obligations, not scope
- Actions by type
- Base award1
- Funding only6
- Option exercised3
- Other administrative action2
- Terminated for convenience1
Similar awards
PIID | Match | Awardee |
|---|---|---|
All contract data
All contract data
Every other field reported for this award, as of its latest reported action
Competition
- Evaluation preference
- No preference used
- Local area set-aside
- No
- Simplified procedures for commercial items
- No
- A-76 (FAIR Act) action
- No
Pricing and financing
- Paid by purchase card
- No
- Latest action: change in base and exercised options
- -$268,010
- Latest action: change in base and all options
- -$268,010
Socio-economic and policy
- Recovered materials and sustainability
- No clauses included and no sustainability includedC
- EPA-designated product
- Meets requirementsA
- Clinger-Cohen Act planning (IT)
- No
- Walsh-Healey Act (materials and supplies)
- No
- Construction wage rates (Davis-Bacon)
- No
Place and origin
- Domestic or foreign entity
- U.S. owned businessA
- Country of product or service origin
- United statesUSA
- Place of manufacture
- Mfg in U.S.D
- Sea transportation
- UnknownU
Structure
- Award or IDV
- Award
- Award type
- Purchase orderB
- IT commercial item category
- Not IT products or servicesZ
- DoD claimant program
- Medical and dental supplies and equipmentC9B
- Awarding agency code
- 9700
- Awarding sub-tier code
- 2100
- Contracting office code
- W81K00
- Transactions recorded under this award key
- 13
Funding
- Funding agency code
- 9700
- Funding sub-tier code
- 97DH
- Funding office code
- HT0852
- Treasury accounts
- 097-2023/2023-0130-000
- 097-2024/2024-0130-000
- Object classes
- 26.0: Supplies and materials
- Disaster or emergency funding (DEFC)
- Q: Not Designated Nonemergency/Emergency/Disaster/Wildfire Suppression